MISSION CREEK CAPITAL PARTNERS, INC. Novo Nordisk A/S Transaction History

MISSION CREEK CAPITAL PARTNERS, INC. portfolio value:

$579,000
portfolio value

MISSION CREEK CAPITAL PARTNERS, INC. quarter portfolio value change:

-10.59%
quarter

Novo Nordisk A/S 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -1.69% -100 shares -80K $99.63 5.81K
Q2 2022 share 0.00% 0 shares 3K $111.43 5.91K
Q1 2022 share 0.00% 0 shares -6K $111.05 5.91K
Q4 2021 share Decrease -3.27% -200 shares 75K $111.45 5.91K
Q3 2021 share Decrease -3.78% -240 shares 55K $96.01 6.11K
Q2 2021 share Decrease -1.55% -100 shares 97K $83.32 6.35K
Q1 2021 share 0.00% 0 shares -16K $67.06 6.45K
Q4 2020 share 0.00% 0 shares 3K $68.52 6.45K
Q3 2020 share Decrease -1.10% -72 shares 21K $68.1 6.45K
Q2 2020 share Decrease -6.79% -475 shares 6K $63.73 6.52K
Q1 2020 share Decrease -1.41% -100 shares 10K $58.59 6.99K
Q4 2019 share Increase 0.00% 7.09K shares 411K $55.56 7.09K